Browse 17 Life Science companies funded by MassChallenge. See funding amounts, founder contacts, and investment details.
Syntr Health Technologies develops and tests a processing device for the micro fragmentation of adipose tissue for body contouring.
Opsin Biotherapeutics develops a pipeline of opsin-based gene therapies for pain management
iSpecimen is the marketplace for human biospecimens, providing researchers with the samples they need from the patients they want.
Reveal Pharmaceuticals is the gadolinium free MRI contrast agent.
Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance.
React4life Srl is an Italian biotech company producing MIVO® (Multi In Vitro Organ), the next generation of organ-on-a-chip.
Symphony Biosciences is a biotech company that develops cancer drugs to help treat solid tumors.
Rqmicro develops a pathogen separation and detection technology that delivers accurate results in less than 2 hours.
Gelatex has invented fast and scalable solution-spinning technology to produce nanofibers for various industries.
Folia Health is a platform that captures and shares secure health and symptom data for users.
Yeastime's value proposition is its innovative retrofitting ultrasound technology, which accelerates fermentation by up to 30%.
Enzymit is a bioproduction platform company based on computational protein design and ‘cell-free' enzymatic manufacturing technology
LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy
TissueLabs is a biotechnology research company that operates a platform for creating organs and tissues in the lab.
Advanced Scanners provide optimal 3D surface mapping for precise intra-operative diagnostics and positioning.
We make Better Cannabinoids through sustainable biotechnology.
Criam is a medtech company developing portable AI-powered devices for rapid, accurate point-of-care blood diagnostics.
View all companies funded by MassChallenge across every industry and funding stage.
View Full MassChallenge Portfolio